pUltra-puro-RTTA3 Citations (5)

Originally described in: pUltra plasmids
Unpublished

---

Articles Citing pUltra-puro-RTTA3

Articles
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Joung J, Kirchgatterer PC, Singh A, Cho JH, Nety SP, Larson RC, Macrae RK, Deasy R, Tseng YY, Maus MV, Zhang F. Nat Commun. 2022 Mar 25;13(1):1606. doi: 10.1038/s41467-022-29205-8. PubMed
Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation. Afifi MM, Crncec A, Cornwell JA, Cataisson C, Paul D, Ghorab LM, Hernandez MO, Wong M, Kedei N, Cappell SD. Cell Rep. 2023 Sep 26;42(9):113079. doi: 10.1016/j.celrep.2023.113079. Epub 2023 Aug 31. PubMed
Tau Axonal Sorting and Interaction With Synaptic Plasticity Modulators Is Domain- and Isoform-Dependent in Human iPSC-Derived Neurons. Bell-Simons M, Breuer H, Wunderlich L, Chmes H, Adam D, Klimek J, Buchholz S, Zempel H. Aging Cell. 2025 Nov;24(11):e70215. doi: 10.1111/acel.70215. Epub 2025 Sep 24. PubMed
SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancer. Duval AJ, Seker-Polat F, Rogozinska M, Kinali M, Walts AE, Neyisci O, Zhang Y, Li Z, Tanner EJ 3rd, Grubbs AE, Orsulic S, Matei D, Adli M. J Clin Invest. 2025 Oct 1;135(19):e186467. doi: 10.1172/JCI186467. eCollection 2025 Oct 1. PubMed
Druggable genome CRISPR screening identifies the KEAP1/NRF2 axis as a mediator of PD-L1 expression. Seker-Polat F, Rogozinska M, Ban Y, Abdula F, Buyukcelebi K, Xie P, Fan J, Abbaszadeh N, Kingham Y, Paylakhi SZ, Zhang B, Adli M. Commun Biol. 2025 Nov 19;8(1):1610. doi: 10.1038/s42003-025-08983-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.